Jarro-Dophilus Infant Probiotic Drops By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Jarro-Dophilus Infant Probiotic Drops
Supplement: Jarro-Dophilus Infant Probiotic Drops by Jarrow Formulas
Jarro-Dophilus Infant Probiotic Drops Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Bifidobacterium longum subsp. infantis (M-63)
| Ingredient Group | Bifidobacterium infantis |
|---|---|
| Category | bacteria |
Drugs that interact with Jarro-Dophilus Infant Probiotic Drops by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Jarro-Dophilus Infant Probiotic Drops. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Infants |
|---|---|
| Minimum serving Sizes: |
0.5 mL
|
| Maximum serving Sizes: |
0.5 mL
|
| Servings per container | 30 |
| UPC/BARCODE | 790011030140 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Bifidobacterium longum subsp. infantis (M-63) |
0 NP
|
Bifidobacterium infantis |
--
|
| Other Ingredients: |
Medium Chain Triglycerides
Tapioca Starch
Calcium Phosphate
Vitamin E
Forms
Citric Acid
|
|---|
Label Statments:
| Formula |
- Bifidobacterium Longum Subsp. Infantis M-63
Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function. B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants. B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.
Jarro-Dophilus Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.
- With clinically documented B. infantis M-63
Documented strain 1 billion live bacteria guaranteed
|
|---|---|
| General Statements |
- The developing intestinal microflora of newborns is up to 90% B. infantis
- Strains Matter: Jarrow Formulas’ Probiotics contain clinically documented strains
|
| Suggested/Recommended/Usage/Directions |
- Usage: For newborns to infants up to 6 months old, add 10 drops, once daily, to foods, lukewarm milk, or an infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use.
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| Storage |
- No refrigeration necessary
Does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77°F (25°C).
|
| Brand IP Statement(s) |
- U.S. patent-pending
2018 Jarrow Formulas
|
| Formulation |
- Vegan
- Gluten free
Dairy free
- Promotes infant intestinal health
- No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
- Suitable for vegans/vegetarians.
|
| FDA Statement of Identity |
- Liquid Probiotic Supplement
|
| Seals/Symbols |
- V Vegan
|
Brand Information
See all products by this brand
| Distributed exclusively by | |
|---|---|
| Name | Jarrow Formulas |
| Street Address | P.O. Box 35994 |
| City | Los Angeles |
| State | CA |
| ZipCode | 90035-4317 |
| Web Address | www.Jarrow.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.